Skip to content

BRALAV-study: Breast Reconstruction; Added Layer, Added Value?

BRALAV-study: Breast Reconstruction; Added Layer, Added Value? - BRALAV-Study

Status
Unknown
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON40855
Enrollment
100
Registered
2014-06-16
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Borstreconstructies Breast cancer breast reconstruction

Interventions

Eligible patients, who give informed consent, will be operated by a plastic surgeon. Skin sparing mastectomy and implant reconstruction will be performed in all patients. Patients will be randomized

Sponsors

Vrije Universiteit Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Females are included if they meet the following criteria: * willing and able to participate; * aged 18 and over; * able to provide informed consent and * able to complete questionnaires.

Exclusion criteria

Exclusion criteria: Exclusion criteria are: * pregnancy or planning a pregnancy during the study; * ongoing severe psychiatric illness or mental retardation; * evidence of alcohol and/or drug abuse; * inability to complete the questionnaires; * local or general infection which could jeopardize the surgical objective; * extensive local inflammatory reactions; * proven or suspected hypersensitivity to materials; * immunosuppressive pathologies.

Design outcomes

Primary

MeasureTime frame
The primary endpoint of the study is the number of reoperations as a result of complications within the first post-operative year

Secondary

MeasureTime frame
Secondary outcomes are: quality of life as measured by a specific breast related questionnaire (BREAST-Q), general quality of life measured with the EQ-5D, complication rate, aesthetic outcome and pain. The BREAST-Q will be administered pre-operatively and at one year after surgery, The EQ-5D is administered every 3 months to collect cost data. Based on these data QALYs will be calculated using the Dutch tariff.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)